Wu Meng-Ying, Kao I-Fang, Yen Shiow-Kang
Department of Materials Science and Engineering, National Chung Hsing University, Taichung 402, Taiwan.
Department of Orthopedics, Taichung Armed Forces General Hospital, Taichung 404, Taiwan.
Polymers (Basel). 2025 May 27;17(11):1485. doi: 10.3390/polym17111485.
Cisplatin, a widely used chemotherapeutic agent, is limited by its poor bioavailability, rapid systemic clearance, and severe side effects. To overcome these limitations, hydroxyapatite-gelatin composite microspheres were developed to improve drug entrapment efficiency (DEE) and provide sustained drug release. Various formulations were prepared by incorporating chitosan either by mixing once or through a sequential coating strategy. By adjusting the loading procedure, the DEE increased from 58% to 99%. The composite microsphere effectively controlled the total drug release duration, extending it from one month to over 5 months. Moreover, the MTT assay demonstrated that all samples effectively inhibited cell growth, with cell viability reduced to less than 20% after 2 weeks of experimentation. These findings demonstrate that the sequential chitosan coating method offers superior drug entrapment and prolonged release compared to mixing chitosan once, exhibiting its potential as a sustained drug delivery system for cancer treatment.
顺铂是一种广泛使用的化疗药物,但因其生物利用度低、全身清除快和副作用严重而受到限制。为了克服这些局限性,人们开发了羟基磷灰石-明胶复合微球,以提高药物包封率(DEE)并实现药物的持续释放。通过一次混合或采用连续包衣策略加入壳聚糖制备了各种制剂。通过调整负载程序,药物包封率从58%提高到了99%。复合微球有效地控制了药物的总释放持续时间,从一个月延长到了5个多月。此外,MTT试验表明,所有样品均能有效抑制细胞生长,实验2周后细胞活力降低至20%以下。这些发现表明,与一次性混合壳聚糖相比,连续壳聚糖包衣方法具有更好的药物包封和延长释放效果,显示出其作为癌症治疗持续给药系统的潜力。
Polymers (Basel). 2025-5-27
Pharmaceutics. 2024-5-29
Mater Sci Eng C Mater Biol Appl. 2019-3-11
Int J Biol Macromol. 2018-12-12
Pharmaceutics. 2024-5-29
Polymers (Basel). 2023-8-8